One Recruitment Group Ltd

*** 🚨 New Opportunity - Multiple Openings 🚨 *** Please Like, Comment & Share for further reach 👍 🖥 Automation Engineer x 2 🌐 Global Biopharma company 📍 Just outside of NYC 🚀 Direct-hire FTE positions 🏠 Hybrid working supported following onboarding ✅ Relocation assistance provided 🔑 Must be US Citizen/Green Card holder ▶ GMP experience is NOT a pre-requisite This is an exciting opportunity to be part of a collaborative team and work on control systems projects with some of the biggest brands across Biotech/Pharma globally. For more information on the positions, the company, the compensation and benefits, drop me a message or send an email to jack.phillips@onerecruitmentgroup.com

Pls Like & Share *****🛎 NEW ROLE 🛎***** ⛑ Manufacturing Engineering Manager 💼 Global Med Tech company 📍 North of Boston Contact myself of Chris Martin for all the details…. 📧 jack.phillips@onerecruitmentgroup.com 📧 chris.martin@onerecruitmentgroup.com

🚨 📣 Quick roundup of the headlines across Biotech/Pharma from the past week 📣 🚨 💊 AstraZeneca has launched a new company, called Evinova, to allow CROs and fellow Big Pharmas to pay to access its tried-and-tested digital solutions for running clinical trials. 💊 Merck invests $610M into acquisition of preclinical neurodegenerative biotech Caraway 💊 Boehringer Ingelheim expands immuno-oncology pipeline through $500m acquisition of Swiss Biotech T3 Pharma 💊 CRISPR Therapeutics laid off employees a week after FDA advisers all but greenlighted the company’s Vertex-partnered, CRISPR-edited sickle cell therapy 💊 Oxurion plans bankruptcy filing following phase 2 eye disease failure 💊 GSK aims to slash carbon emissions with next-generation inhaler which has the potential to slash greenhouse gas emissions by roughly 90% 💊 Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast 💊 Bayer pulls batch of cancer med Vitrakvi over bacterial contamination concerns 💊 Amid ADHD drug shortage, industry group points a finger at government manufacturing restrictions 💊 Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of RSV antibody Beyfortus

💹 October layoffs in numbers... Total number of companies affected = 1️⃣ 6️⃣ 💉 Syros Pharmaceuticals - 35% of staff + CEO 💉 Kezar Life Sciences - 41% of staff + CEO + CMO 💉 Uniqure - 114 positions including CSO 💉 Atsena Therapeutics - 42 staff 💉 Nanostring Technologies - 110 staff 💉 Eikon Therapeutics - 10% of staff 💉 Sana Biotechnology - 29% of global workforce 💉 Biogen - 113 positions in Texas 💉 Nkarta - 10% of staff 💉 Beam Therapeutics - 100 members of staff 💉 Brainstorm Cell Therapeutics - 30% of staff including CMO 💉 Idorsia - 300 employees + 175 open/backfill vacancies 💉 Amgen - 350 employees 💉 ElevateBio - 13% of the workforce 💉 Pfizer - 791 employees in New Jersey 💉 Galapagos - 400 positions cut with plans to cut a further 100 If you've been affected or know somebody who has, I am here to help! You can reach me via LinkedIn and email: jack.phillips@onerecruitmentgroup.com